Stephen J. Polyak
University of Washington
H-index: 54
North America-United States
Top articles of Stephen J. Polyak
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Methods of modeling in vivo efficacy of drug combinations for treatment of viral infections | 2024/4/18 | ||
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents | Antimicrobial Agents and Chemotherapy | Shuang Xu Shadisadat Esmaeili E Fabian Cardozo-Ojeda Ashish Goyal Judith M White | 2024/4/3 |
A unifying model to explain high nirmatrelvir therapeutic efficacy, low post-exposure prophylaxis efficacy, and frequent viral rebound | medRxiv | Shadisadat Esmaeili Katherine Owens Jessica Wagoner Stephen J Polyak Judith M White | 2024/1/30 |
Virology under the microscope—a call for rational discourse | Journal of virology | Felicia Goodrum Anice C Lowen Seema Lakdawala James Alwine Arturo Casadevall | 2023/2/28 |
Antiviral efficacy of approved antiviral drugs and combinations thereof against CHIKV in human skin fibroblasts and AG129 mice | Sam Verwimp Rana Abdelnabi Johan Neyts Stephen J Polyak Leen Delang | 2023/9/25 | |
A unifying model to explain nirmatrelvir/ritonavir’s high efficacy during early treatment and low efficacy as post-exposure prophylaxis, and to predict viral rebound | S Esmaeili K Owens J Wagoner SJ Polyak JT Schiffer | 2023/8/24 | |
Inhibition of arenaviruses by combinations of approved therapeutic drugs | 2023/7/6 | ||
Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy | AIDS | Tecla M Temu Stephen J Polyak Celestine N Wanjalla Nelson Aringo Mandela Smritee Dabee | 2023/6/1 |
Modulation of in Vitro SARS-CoV-2 Infection by Stephania tetrandra and Its Alkaloid Constituents | Journal of Natural Products | Aswad Khadilkar Zoie L Bunch Jessica Wagoner Vandana Ravindran Jessica M Oda | 2023/4/12 |
Discovery of host-directed modulators of virus infection by probing the SARS-CoV-2–host protein–protein interaction network | Briefings in Bioinformatics | Vandana Ravindran Jessica Wagoner Paschalis Athanasiadis Andreas B Den Hartigh Julia M Sidorova | 2022/11 |
Combinations of host-and virus-targeting antiviral drugs confer synergistic suppression of SARS-CoV-2 | Microbiology spectrum | Jessica Wagoner Shawn Herring Tien-Ying Hsiang Aleksandr Ianevski Scott B Biering | 2022/10/26 |
Mono-and combinational drug therapies for global viral pandemic preparedness | Aleksandr Ianevski Rouan Yao Ronja M Simonsen Vegard Myhre Erlend Ravlo | 2022/4/15 | |
Broad-spectrum mono-and combinational drug therapies for global viral pandemic preparedness | bioRxiv | Aleksandr Ianevski Rouan Yao Ronja M Simonsen Vegard Myhre Erlend Ravlo | 2022/1/15 |
Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya | AIDS | Tecla M Temu Jerry S Zifodya Stephen J Polyak Jessica Wagoner Celestine N Wanjalla | 2021/1/1 |
Inhibition of arenaviruses by combinations of orally available approved drugs | Antimicrobial agents and chemotherapy | Shawn Herring Jessica M Oda Jessica Wagoner Delaney Kirchmeier Aidan O’Connor | 2021/3/18 |
Drug combinations as a first line of defense against coronaviruses and other emerging viruses | Judith M White Joshua T Schiffer Rachel A Bender Ignacio Shuang Xu Denis Kainov | 2021/12/21 | |
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice | Molecular Therapy-Methods & Clinical Development | Daniel Stone Kelly R Long Michelle A Loprieno Harshana S De Silva Feelixge Elizabeth J Kenkel | 2021/3/12 |
Evaluation of the potential of botanicals and their constituents against the SARS-CoV-2 virus | Planta Medica | Nadja B Cech Aswad Khadilkar Jessica Wagoner Trevor Clark Preston Manwill | 2021/12 |
Human immunodeficiency virus is associated with higher levels of systemic inflammation among Kenyan adults despite viral suppression | Clinical Infectious Diseases | Sarah J Masyuko Stephanie T Page Stephen J Polyak John Kinuthia Alfred O Osoti | 2021/10/1 |
Liver abnormalities after elimination of HCV infection: persistent epigenetic and immunological perturbations post-cure | Stephen J Polyak I Nicholas Crispe Thomas F Baumert | 2021/1/7 |